AMERICAN UROGYNECOLOGIC SOCIETY (EIN 953388558) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1979

Legal Domicile

Principal Officer

STACEY BARNES

Phone

3012730570

Tax Period

2024-07-01 to 2025-06-30

AMERICAN UROGYNECOLOGIC SOCIETY, founded in 1979, is a community nonprofit in the Diseases & Disorders sector that reported $3.8M in total revenue in fiscal year 2024. Expenses of $3.5M left a modest 9% surplus.

Mission

TO DEFINE AND CHAMPION EXCELLENCE IN UROGYNECOLOGY AND RECONSTRUCTIVE PELVIC SURGERY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $701,888

Program Service Revenue $2,594,455

Investment Income $210,889

Other Revenue $330,636

TOTAL REVENUE $3,837,868

Expense Breakdown

Grants Paid $115,759

Salaries & Benefits $1,157,896

Fundraising Expenses $0

Program Expenses $2,440,000

Other Expenses $2,216,582

TOTAL EXPENSES $3,490,237

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,837,868	$3,650,464	+0.1%
Expenses	$3,490,237	$3,122,436	+0.1%
Net Income	$347,631	$528,028	-0.3%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$220,698

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TANAZ FERZANDI MD PRES-ELECT	UNTIL DEC. 2024, THEN PRESIDENT	2.00	Officer Director	$0	$0	$0
EMILY LUKACZ MD VP UNTIL	DEC. 2024, THEN PRES.-ELECT	2.00	Officer Director	$0	$0	$0
ROBERT GUTMAN MD DIRECTOR	UNTIL DEC. 2024, THEN VP	2.00	Officer Director	$0	$0	$0
JEROME YAKLIC MD MBA FACOG	TREASURER AS OF JAN. 2025	2.00	Officer Director	$0	$0	$0
JENNIFER WU MD PRES UNTIL	DEC. 2024, IMM. PAST PRES.	2.00	Officer Director	$0	$0	$0
CATHERINE BRADLEY MD	IMM. PAST PRESIDENT UNTIL DEC. 2024	2.00	Officer Director	$0	$0	$0
DOBIE GILES MD	TREASURER UNTIL DEC. 2024	2.00	Officer Director	$0	$0	$0
MARIANNA ALPERIN MD	DIRECTOR	2.00	Director	$0	$0	$0
MATTHEW BARKER MD	DIRECTOR	2.00	Director	$0	$0	$0
HEIDI BROWN MD	DIRECTOR	2.00	Director	$0	$0	$0
NATHAN KOW MD	DIRECTOR	2.00	Director	$0	$0	$0
NAZEMA SIDDIQUI MD	DIRECTOR	2.00	Director	$0	$0	$0
SCOTT SMILEN MD PHD	DIRECTOR AS OF JAN. 2025	2.00	Director	$0	$0	$0
MARCELLA WILLIS-GRAY MD	DIRECTOR AS OF JAN. 2025	2.00	Director	$0	$0	$0
GINA NORTHINGTON MD	DIRECTOR UNTIL DEC. 2024	2.00	Director	$0	$0	$0
STACEY BARNES	CEO AND EXECUTIVE DIRECTOR	40.00	Officer	$190,763	$29,935	$220,698
WEIYI ZHAO	SENIOR DIRECTOR, EDUCATION	40.00	Highest	$157,206	$8,820	$166,026
JENNIFER DEAN SR DIRECTOR	GOVERNANCE AND ENGAGEMENT	40.00	Highest	$113,240	$24,664	$137,904
VERONICA VALDERRAMA	SR. DIRECTOR, PUBLICATIONS	40.00	Highest	$118,173	$14,893	$133,066

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$3,837,868	$3,490,237	$4,175,013	$347,631
2024	$3,650,464	$3,122,436	$3,905,096	$528,028
2023	$2,168,676	$2,395,279	$3,401,589	$-226,603
2022	$5,937,935	$5,297,480	$3,881,810	$640,455
2022	$5,937,935	$5,297,480	$3,881,810	$640,455
2021	$2,686,876	$3,149,850	$2,850,090	$-462,974
2020	$5,371,840	$5,393,694	$3,003,575	$-21,854
2019	$4,346,161	$4,439,811	$4,136,432	$-93,650
2018	$4,138,607	$4,023,406	$3,138,730	$115,201

AMERICAN UROGYNECOLOGIC SOCIETY